// App-Quantinova.ai

e18510 : A single-institution experience with the hyper-CVAD regimen in aggressive NHL.

Researchers

Presenter

  • Mariam Younas

Principal Investigators

  • Stephanie A. Gregory

  • Ahmad Jajeh

  • Melissa L. Larson

  • Taha Al-Rifai

Medical Centers

  • Rush University Medical Center, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A